VELA Investment Management’s Axsome Therapeutics AXSM Stock Holding History

VELA Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294K	Buy	+1,200	New	+$260K	0.06%	157

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

VELA Investment Management's AXSM Position: Q2 2026 in Review

VELA Investment Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 1,200 shares worth $294K. The stake represents 0.06% of the portfolio and ranks #157 among its holdings.

119 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

VELA Investment Management held 1,200 shares of Axsome Therapeutics worth $294K as of Q2 2026.
Axsome Therapeutics was a new VELA Investment Management position in Q2 2026.
Axsome Therapeutics made up 0.06% of VELA Investment Management's portfolio in Q2 2026, its #157 holding.
119 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on VELA Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.